Continuous Infusion of Amphotericin B Deoxycholate: A Cost-Effective Gold Standard for Therapy of Invasive Fungal Infections?

Schneemann, Markus; Bachli, Esther B.
January 2004
Clinical Infectious Diseases;1/15/2004, Vol. 38 Issue 2, p303
Academic Journal
Comments on the cost-effectiveness of continuous infusion of amphotericin B deoxycholate (AmBD) for therapy of invasive fungal infections. Number of patients who develop acute renal failure while receiving therapy with AmBD; Combination of antifungal treatment with daily monitoring and aggressive correction of electrolyte levels and hydration; Expensiveness of lipid formulations of amphotericin B.


Related Articles

  • 400. Consider alternative agents for fungal infections in patients at high risk of acute renal failure. Bates, D.W.; Su, L.; Yu, D.T. // Kidney;May/Jun2002, Vol. 11 Issue 3, p133 

    Deals with a study which examined the correlates of acute renal failure in patients receiving parenteral amphotericin B. Methodology; Results; Conclusion.

  • Correlates of acute renal failure in patients receiving parenteral amphotericin B. Bates, David W.; Su, Ling; Yu, Donghui T.; Chertow, Glenn M.; Seger, Diane L.; Gomes, Daniel R.J.; Platt, Richard // Kidney International;Oct2001, Vol. 60 Issue 4, p1452 

    Correlates of acute renal failure in patients receiving parenteral amphotericin B. Background. While parenteral amphotericin B is an effective therapy for serious fungal infections, it frequently causes acute renal failure (ARF). This study identified correlates of ARF in amphotericin B therapy...

  • Amphotericin-B.  // Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p30 

    The article is a case report of a 32-year-old female with acute renal failure developed while being treated for amphotericin-B.

  • Amphotericin B/cefepime/fluconazole/tretinoin.  // Reactions Weekly;3/3/2012, Issue 1391, p8 

    The article describes the case of a 47-year-old woman who developed acute renal failure while under cefepime, tretinoin, fluconazole and amphotericin B treatment regimen for acute promyelocytic leukaemia.

  • Amphotericin B/itraconazole.  // Reactions Weekly;2/11/2012, Issue 1388, p6 

    The article describes the case of a 32-year-old man who developed acute renal failure and hypersensitivity while receiving amphotericin B and itraconazole for chronic pulmonary blastomycosis.

  • Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections: Results of the Collaborative Exchange of Antifungal Research (CLEAR), an Industry-Supported Patient Registry. Pappas, Peter G. // Clinical Infectious Diseases;5/1/2005 Supplement, Vol. 40, pS379 

    This article focuses on the use of amphotericin B lipid complex (ABLC) for the treatment of invasive fungal infections. ABLC is a composition of amphotericin B and 2 phospholipids, dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol, in a 1:1 drug-to-lipid molar ratio. ABLC was...

  • Reply. Ostrosky-Zeichner, Luis; Marr, Kieren A.; Rex, John H.; Cohen, Stuart H. // Clinical Infectious Diseases;1/15/2004, Vol. 38 Issue 2, p306 

    Comments on the use of lipid formulations of amphotericin B in treating invasive fungal infections. Possibility of using continuous infusions of amphotericin B deoxycholate (AmBD); Limited comparative data supporting the efficacy of continuously infused AmBD; Link of short- and long-term...

  • Amphotericin B.  // Reactions Weekly;4/3/2004, Issue 995, p6 

    Presents a reference to case reports on acute renal failure induced by amphotericin B in the treatment of invasive aspergillesis in patients with acute myeloblastic leukemia.

  • Amphotericin B liposomal.  // Reactions Weekly;7/1/2013, Issue 1459, p7 

    The article presents a case study of a 41-year-old woman with acute renal failure, which developed after receiving amphotericin B liposomal for Cryptococcal osteomyelitis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics